- Report
- August 2025
- 594 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 464 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 468 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 381 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 282 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 580 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 568 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 222 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 279 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 371 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 173 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 159 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 179 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 197 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 193 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 292 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 216 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- August 2025
- 573 Pages
Global
From €5193EUR$5,850USD£4,534GBP
- Report
- July 2025
- 188 Pages
Global
From €3995EUR$4,500USD£3,488GBP
- Report
- March 2025
- 185 Pages
Global
From €3995EUR$4,500USD£3,488GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more